RemoteA Ltd is developing a unique and revolutionary solution, an algorithm and service platform with which ECG data can be automatically analysed and interpreted.
SmartECG is the first and only automatic clinical decision support solution that will be compatible with 80 % of different ECG-monitoring devices and suitable for primary and secondary care professionals.
Our solution will help heart patients get to treatment faster.
SmartECG willl be ready for full scale market introduction in 2018.
SmartECG is a software-based tool for the treatment of cardiovascular diseases (CVD) for primary and secondary care professionals that:
Cardiovascular Disease poses a serious health problem in the EU area and also globally.
SmartECG empowers GPs with a tool for automatic pre-selection and interpretation of most imporatnt analysis data from most ECG devices, leading to:
For patients SmartECG means faster diagnosis and better treatment of cardiovascular diseases. Today, it is common that GP’s will limit the number of patients they refer to the tests since they know that the waiting lists are too long already (suppressed demand).
The SmartECG is expected to increase primary care level specialists’ competencies in early ECG diagnosing and for requesting more specific consultations from specialist physicians.
SmartECG automatic data analysis and pre-selection can reduce the total data amount by 99% and present physicians only the most relevant bits of analysis data. This enables to perform 2-3 times longer and more detailed ECG analysis
Based on our private studies using data from Finland (2013), about 70% of long-term ECG consultation reports do not recommend secondary care studies and they can be avoided by more competent primary care analysis. This will reduce healthcare waiting lists, avoid duplicating analysis and lower the treatment cost per patient. It is expected that by 2020, around 46% of long ECG analysis are done at primary care level.
The consulting specialists that provide primary care physicians the cardiac consultations needed, will be paid for per each remote consultation, depending on their set cost and rewarded either monthly or quarterly, depending on the number of their completed consultations.
Our goal is to create automatic plug-and-play compatibility for 80% of ECG analysis equipment in primary care level and achieve full compatibility with most eHealth systems in targeted countries by 2020.
Mr. Ossi Tiihonen, Managing Director and founder, ossi.tiihonen(at)remotea.com, tel. +358 40 506 5547
Mr. Tuomas Harju, Director of New Business Development, tuomas.harju(at)remotea.com, tel. +358 (0) 45 1315 510
Please subcsribe to our newsletter in the form in the footer, and we will keep you posted by sending newsletters a couple of times duriing the year.
SmartECG is co-funded by the Horizon 2020 programme that helps high-potential SMEs to develop groundbreaking innovative ideas for products, services or processes that are ready to face global market competition.
RemoteA Ltd. was one of the four ICT companies to receive funding of the total 104 ICT companies applying for it, and RemoteA Ltd. also received the highest scores.